Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
ALK1 signaling is required for the homeostasis of Kupffer cells and prevention of bacterial infection
Dianyuan Zhao, … , Fuchu He, Li Tang
Dianyuan Zhao, … , Fuchu He, Li Tang
Published December 7, 2021
Citation Information: J Clin Invest. 2022;132(3):e150489. https://doi.org/10.1172/JCI150489.
View: Text | PDF
Research Article Immunology

ALK1 signaling is required for the homeostasis of Kupffer cells and prevention of bacterial infection

  • Text
  • PDF
Abstract

Macrophages are highly heterogeneous immune cells that fulfill tissue-specific functions. Tissue-derived signals play a critical role in determining macrophage heterogeneity. However, these signals remain largely unknown. The BMP receptor activin receptor–like kinase 1 (ALK1) is well known for its role in blood vessel formation; however, its role within the immune system has never been revealed to our knowledge. Here, we found that BMP9/BMP10/ALK1 signaling controlled the identity and self-renewal of Kupffer cells (KCs) through a Smad4-dependent pathway. In contrast, ALK1 was dispensable for the maintenance of macrophages located in the lung, kidney, spleen, and brain. Following ALK1 deletion, KCs were lost over time and were replaced by monocyte-derived macrophages. These hepatic macrophages showed significantly reduced expression of the complement receptor VSIG4 and alterations in immune zonation and morphology, which is important for the tissue-specialized function of KCs. Furthermore, we found that this signaling pathway was important for KC-mediated Listeria monocytogenes capture, as the loss of ALK1 and Smad4 led to a failure of bacterial capture and overwhelming disseminated infections. Thus, ALK1 signaling instructs a tissue-specific phenotype that allows KCs to protect the host from systemic bacterial dissemination.

Authors

Dianyuan Zhao, Fengjiao Yang, Yang Wang, Site Li, Yang Li, Fei Hou, Wenting Yang, Di Liu, Yuandong Tao, Qian Li, Jing Wang, Fuchu He, Li Tang

×

Figure 3

Maintenance of KCs requires ALK1 signaling.

Options: View larger image (or click on image) Download as PowerPoint
Maintenance of KCs requires ALK1 signaling.
(A) Schematic of the experim...
(A) Schematic of the experimental setup. (B) Expression of CD45.1 (donor) and CD45.2 (recipient) in blood monocytes and total KCs from Alk1fl/fl and Alk1fl/fl Clec4f Cre chimeras. Plot shows the percentage of total chimerism of KCs in Alk1fl/fl and Alk1fl/fl Clec4f Cre chimeras (n = 6 per group). The experimental setup was as indicated in A. (C) Expression of Clec4F and Tim4 and percentage of Clec4F–Tim4+ and Tim4– cells in KCs from Alk1fl/fl Clec4f Cre mice and Alk1fl/fl control mice at 2, 5, and 12 weeks of age (n = 7–12 per group). (D) Representative flow cytometric data and quantification of EdU incorporation in Clec4F–Tim4+, Clec4F+Tim4+, and Tim4– KCs from Alk1fl/fl Clec4f Cre mice and Alk1fl/fl controls (n = 6–7 per group). (E) The chimeric mice were treated with tamoxifen (10 mg) 2 times every other day via oral gavage. Clec4F and Tim4 expression in KCs originated from CD45.2+ donor cells was assessed 5, 10, and 25 days after the last treatment (n = 4–8 per group). Results represent the mean ± SEM. **P < 0.01, ***P < 0.001, and ****P < 0.0001, by 2-tailed Student’s t test (B) and 1-way ANOVA (C–E).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts